# IOBENGUANE I-123
> **ANDA213637** · Abbreviated New Drug Application (Generic) · Sponsor: BWXT MEDCL · Approved 2024-12-09
## Drug
- **FDA Application Number:** ANDA213637
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IOBENGUANE I-123
- **Generic name:** Iobenguane Sulfate I-123
- **Active ingredients:** IOBENGUANE SULFATE I-123
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** BWXT MEDCL
- **First approval:** 2024-12-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213637)
---
*AI Analytics · CC0 1.0*